↓ Skip to main content

Dove Medical Press

Article Metrics

A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy
1 policy source
twitter
4 tweeters

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
71 Mendeley
Title
A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
Published in
Therapeutics and Clinical Risk Management, July 2009
DOI 10.2147/tcrm.s5176
Pubmed ID
Authors

Su Hline

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 4%
United Kingdom 1 1%
South Africa 1 1%
New Zealand 1 1%
Canada 1 1%
Unknown 64 90%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 20%
Researcher 8 11%
Student > Postgraduate 8 11%
Student > Ph. D. Student 7 10%
Student > Master 6 8%
Other 16 23%
Unknown 12 17%
Readers by discipline Count As %
Medicine and Dentistry 30 42%
Pharmacology, Toxicology and Pharmaceutical Science 12 17%
Nursing and Health Professions 7 10%
Agricultural and Biological Sciences 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 2 3%
Unknown 15 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2021.
All research outputs
#5,200,748
of 20,886,305 outputs
Outputs from Therapeutics and Clinical Risk Management
#247
of 1,204 outputs
Outputs of similar age
#60,714
of 225,766 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#6
of 53 outputs
Altmetric has tracked 20,886,305 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,204 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,766 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.